Fortrea Holdings (FTRE) Total Current Liabilities (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly Total Current Liabilities came in at $963.7 million in Q2 2026, up 2.27% YoY from $942.3 million in Q2 2025, and up 3.72% on a QoQ basis from $929.1 million in Q1 2026.

Fortrea Holdings (FTRE) Total Current Liabilities (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has 5 years of Total Current Liabilities data on file, last reported at $963.7 million in Q2 2026.

  • Quarterly Total Current Liabilities rose 2.27% year-over-year to $963.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $963.7 million (up 2.27% YoY) and the FY2025 annual result came in at $913.3 million, down 3.81% from the prior year.
  • Total Current Liabilities climbed to $963.7 million in Q2 2026, from $929.1 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $999.1 million in Q1 2025 to a low of $699.0 million in Q4 2022.
  • A 5-year average of $855.6 million and a median of $865.8 million in 2024 frame the typical range for Total Current Liabilities.
  • Annual changes were most pronounced in 2025 — Total Current Liabilities climbed 25.81% — and 2026, when it slipped 7.01%.
  • Tracing FTRE's Total Current Liabilities over 5 years: stood at $699.0 million in 2022, then increased by 11.36% to $778.4 million in 2023, then grew by 21.98% to $949.5 million in 2024, then retreated by 3.81% to $913.3 million in 2025, then increased by 5.52% to $963.7 million in 2026.
  • The last three Total Current Liabilities figures came in at $963.7 million (Q2 2026), $929.1 million (Q1 2026), and $913.3 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.58 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 354.06 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 2.12 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 4.22 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 630.93 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.51 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 438.74 Mn
10 Fortrea Holdings 1.66 Bn 1.49 Bn 139.20 Mn 963.70 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 963.70 Mn
Mar 31, 2026 929.10 Mn
Dec 31, 2025 913.30 Mn
Sep 30, 2025 914.40 Mn
Jun 30, 2025 942.30 Mn
Mar 31, 2025 999.10 Mn
Dec 31, 2024 949.50 Mn
Sep 30, 2024 795.80 Mn
Jun 30, 2024 749.00 Mn
Mar 31, 2024 818.30 Mn
Dec 31, 2023 778.40 Mn
Sep 30, 2023 774.60 Mn
Jun 30, 2023 752.10 Mn
Dec 31, 2022 699.00 Mn